Walleye Capital LLC Agenus Inc Transaction History

Walleye Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$1.3 - $2.64 $87,240 - $177,165	-67,108 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.35 - $3.47 $157,703 - $232,864	67,108 New	67,108 $165,000
Q4 2021 Mar 03, 2022	SELL	$2.92 - $5.74 $166,258 - $326,824	-56,938 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.98 - $6.63 $231,166 - $307,757	46,419 Added 441.29%	56,938 $299,000
Q2 2021 Aug 16, 2021	SELL	$2.56 - $5.49 $93,391 - $200,280	-36,481 Reduced 77.62%	10,519 $58,000
Q1 2021 May 17, 2021	BUY	$2.69 - $5.25 $126,430 - $246,750	47,000 New	47,000 $128,000
Q3 2020 Nov 16, 2020	SELL	$2.98 - $5.2 $56,620 - $98,800	-19,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.29 - $4.24 $43,510 - $80,560	19,000 New	19,000 $75,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.